Pivotal prices moved up further on continued buying support from foreign institutional investors and bull operators on the National Stock Exchange (NSE) yesterday.
The NSE-50 index opened steady at 1,100.85 points, touched days high of 1,112.40 points, low of 1,098.35 points and closed at 1,111.35 points, showing a net gain of 10.50 points as against its previous days close of 1,100.85 points.
Midcap index closed at 1,247.75 points over the last trading days close of 1,245.10 points gaining 2.65 points. The total turnover on the exchange was Rs 1898.04 crore involving 594.72 lakh shares and the number of trades were 1,48,533. The total turnover at the segment was Rs 72.46 lakh. Among the gainers were Cochin Refineries, G E Shipping, ITC, Tata Power and MTNL, while losers were T V Suzuki, Gujarat Amb Cement, EIH Limited, ICICI and Essar Steel.
More From This Section
Hectic trading was witnessed at the following counters: ITC (Rs 964.72 cr), RIL (Rs 347.86 cr), Tata Tea (Rs 162.94 cr), SBI-N (Rs 102.93 cr), Satyam Comp (Rs 45.72 cr), ICICI Bank (Rs 37.55 cr), Castrol (Rs 31.58 cr), Tisco (Rs 17.68 cr), Telco (Rs 17.68 cr), BHEL (Rs 15.74 cr), ACC (Rs 14.52 cr), HLL (Rs 13.141 cr), Bajaj Auto (Rs 12.58 cr), Ponds (Rs 11.25 cr), Colgate (Rs 9.26 cr), MTNL (Rs 7.33 cr), Guj Amb Cement (Rs 5.84 cr), L&T (Rs 5.33 cr), Infosystch (Rs 5.08 cr), TVS Suzuki (Rs 3.63 cr), ICICI (Rs 3.53 cr), BSES (Rs 3.23 cr), REL Capital (Rs 2.22 cr), IPCL (Rs 2.18 cr) and Cochin Refn (Rs 2.08 cr).
Meanwhile, the Over the Counter (OTC) Exchange of India successfully completed the second settlement in the permitted securities segment. There were no shortages in securities to be delivered and there were no defaults in the payin.
The exchange also completed its third trading cycle. The total turnover for the trading cycle was Rs 11.96 crore, comprising of 5,73,670 shares. The first day of the fourth trading cycle saw a turnover of Rs 2.95 crore brisk activity was witnessed in Reliance, SBI, ITC, Associated Cement Company, Indian Hotels, Tata Power among others, according to an OTC press release.